134 related articles for article (PubMed ID: 27754705)
21. Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer.
Guo M; House MG; Suzuki H; Ye Y; Brock MV; Lu F; Liu Z; Rustgi AK; Herman JG
Int J Cancer; 2007 Sep; 121(6):1219-26. PubMed ID: 17534889
[TBL] [Abstract][Full Text] [Related]
22. CDX2 serves as a Wnt signaling inhibitor and is frequently methylated in lung cancer.
Liu X; Zhang X; Zhan Q; Brock MV; Herman JG; Guo M
Cancer Biol Ther; 2012 Oct; 13(12):1152-7. PubMed ID: 22892849
[TBL] [Abstract][Full Text] [Related]
23. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
24. Methylation of promoter region of
Wang Y; Li Z; Li W; Liu S; Han B
Oncol Lett; 2016 Nov; 12(5):3229-3233. PubMed ID: 27899987
[TBL] [Abstract][Full Text] [Related]
25. Recombinant lentivirus with enhanced expression of caudal-related homeobox protein 2 inhibits human colorectal cancer cell proliferation in vitro.
He S; Sun XJ; Zheng JB; Qi J; Chen NZ; Wang W; Wei GB; Liu D; Yu JH; Lu SY; Wang H
Mol Med Rep; 2015 Aug; 12(2):1838-44. PubMed ID: 25847407
[TBL] [Abstract][Full Text] [Related]
26. Relationships between the expressions of CDX1 and CDX2 mRNA and clinicopathologic features in colorectal cancers.
Kim GH; Lee DH; Kim HW; Cheong JY; Seo SB; Heo J; Kang DH; Song GA; Cho M; Yang US; Park DY; Yoo MA
Korean J Intern Med; 2005 Dec; 20(4):317-24. PubMed ID: 16491830
[TBL] [Abstract][Full Text] [Related]
27. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
28. Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer.
Xu W; Zhu Y; Shen W; Ding W; Wu T; Guo Y; Chen X; Zhou M; Chen Y; Cui L; Du P
J Int Med Res; 2019 May; 47(5):1829-1842. PubMed ID: 30616445
[TBL] [Abstract][Full Text] [Related]
29. MGMT promoter methylation and field defect in sporadic colorectal cancer.
Shen L; Kondo Y; Rosner GL; Xiao L; Hernandez NS; Vilaythong J; Houlihan PS; Krouse RS; Prasad AR; Einspahr JG; Buckmeier J; Alberts DS; Hamilton SR; Issa JP
J Natl Cancer Inst; 2005 Sep; 97(18):1330-8. PubMed ID: 16174854
[TBL] [Abstract][Full Text] [Related]
30. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
31. CDX2 Protein Expression in Colorectal Cancer and ItsCorrelation with Clinical and Pathological Characteristics, Prognosis, and Survival Rate of Patients.
Asgari-Karchekani S; Karimian M; Mazoochi T; Taheri MA; Khamehchian T
J Gastrointest Cancer; 2020 Sep; 51(3):844-849. PubMed ID: 31630373
[TBL] [Abstract][Full Text] [Related]
32. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
33. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of CDX2 in colorectal cancers.
Choi BJ; Kim CJ; Cho YG; Song JH; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
APMIS; 2006 Jan; 114(1):50-4. PubMed ID: 16499661
[TBL] [Abstract][Full Text] [Related]
35. Reduced CDX2 expression predicts poor overall survival in patients with colorectal cancer.
Hong KD; Lee D; Lee Y; Lee SI; Moon HY
Am Surg; 2013 Apr; 79(4):353-60. PubMed ID: 23574843
[TBL] [Abstract][Full Text] [Related]
36. Chemopreventive activity of GEN-27, a genistein derivative, in colitis-associated cancer is mediated by p65-CDX2-β-catenin axis.
Du Q; Wang Y; Liu C; Wang H; Fan H; Li Y; Wang J; Zhang X; Lu J; Ji H; Hu R
Oncotarget; 2016 Apr; 7(14):17870-84. PubMed ID: 26910375
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
Zheng J; Sun X; Wang W; Lu S
Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
[TBL] [Abstract][Full Text] [Related]
38. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.
Menigatti M; Truninger K; Gebbers JO; Marbet U; Marra G; Schär P
Oncogene; 2009 Feb; 28(6):899-909. PubMed ID: 19060925
[TBL] [Abstract][Full Text] [Related]
39. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients.
Yuasa Y; Nagasaki H; Akiyama Y; Sakai H; Nakajima T; Ohkura Y; Takizawa T; Koike M; Tani M; Iwai T; Sugihara K; Imai K; Nakachi K
Carcinogenesis; 2005 Jan; 26(1):193-200. PubMed ID: 15498792
[TBL] [Abstract][Full Text] [Related]
40. Double Negativity for Expression of YAP1 and CDX2 Defines an Aggressive Type of Colitis-associated Cancer.
Yin F; Xie H; Lai J; Chen Y; Dong J; Zhang X; Liu X
Anticancer Res; 2020 Oct; 40(10):5411-5416. PubMed ID: 32988861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
